AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 101 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $1,440,000 | +110.8% | 484,936 | +5.8% | 0.00% | – |
Q2 2016 | $683,000 | -82.1% | 458,386 | -55.6% | 0.00% | -100.0% |
Q1 2016 | $3,821,000 | -76.8% | 1,032,702 | -36.7% | 0.00% | -75.0% |
Q4 2015 | $16,466,000 | -19.9% | 1,630,272 | +7.9% | 0.00% | -20.0% |
Q3 2015 | $20,544,000 | -13.6% | 1,510,603 | +20.6% | 0.01% | -16.7% |
Q2 2015 | $23,771,000 | -40.5% | 1,253,058 | -18.0% | 0.01% | -40.0% |
Q1 2015 | $39,982,000 | +49.8% | 1,527,768 | +19.9% | 0.01% | +42.9% |
Q4 2014 | $26,691,000 | -35.6% | 1,274,634 | +2.7% | 0.01% | -41.7% |
Q3 2014 | $41,442,000 | +4.7% | 1,241,516 | +0.7% | 0.01% | +9.1% |
Q2 2014 | $39,569,000 | -23.7% | 1,233,068 | +9.9% | 0.01% | -26.7% |
Q1 2014 | $51,827,000 | -37.9% | 1,122,282 | -4.6% | 0.02% | -40.0% |
Q4 2013 | $83,436,000 | -15.7% | 1,175,824 | +1.8% | 0.02% | -24.2% |
Q3 2013 | $99,030,000 | +57.2% | 1,154,871 | +16.1% | 0.03% | +43.5% |
Q2 2013 | $63,009,000 | – | 994,775 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 4,656,682 | $399,310,000 | 16.44% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,300,000 | $111,475,000 | 5.48% |
ADVENT INTERNATIONAL, L.P. | 705,300 | $60,479,000 | 5.01% |
Antipodean Advisors LLC | 266,400 | $22,844,000 | 2.38% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 489,181 | $41,928,000 | 2.06% |
HealthCor Management, L.P. | 425,000 | $36,444,000 | 1.95% |
Cupps Capital Management, LLC | 290,489 | $24,909,000 | 1.62% |
Zweig-DiMenna Associates LLC | 421,400 | $36,135,000 | 1.46% |
SABBY MANAGEMENT, LLC | 259,119 | $22,209,000 | 1.44% |
Independence Capital Asset Partners, LLC | 98,070 | $8,410,000 | 1.43% |